We used genetically modified mice overexpressing the cytokine transforming growth factor beta 1 (TGF mice) that capture several aspects of the cerebrovascular pathology present in Alzheimer’s disease and vascular cognitive impairment and dementia. This evidence concerns the gene TGFB1 and early-onset autosomal dominant Alzheimer disease.